XML 39 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)
 3 Months Ended
Jul. 01, 2017
Segment Reporting [Abstract]  
Selected Information by Business Segment
Selected information by business segment is presented below:
 
Three Months Ended
(In thousands)
July 1,
2017
 
July 2,
2016
Net revenues
 
 
 
Japan
$
15,232

 
$
14,566

EMEA
43,008

 
45,741

North America Plasma
77,536

 
73,475

All Other
78,174

 
78,020

Net revenues before foreign exchange impact
213,950

 
211,802

Effect of exchange rates
(2,999
)
 
(1,846
)
Net revenues
$
210,951

 
$
209,956

 
Three Months Ended
(In thousands)
July 1,
2017
 
July 2,
2016
Segment operating income
 
 
 
Japan
$
6,738

 
$
6,156

EMEA
8,571

 
8,276

North America Plasma
24,102

 
25,168

All Other
27,686

 
27,170

Segment operating income
67,097

 
66,770

  Corporate operating expenses
(39,311
)
 
(46,139
)
  Effect of exchange rates
(2,201
)
 
(1,306
)
Restructuring and turnaround costs
(2,483
)
 
(18,816
)
Deal amortization
(6,491
)
 
(7,075
)
Asset impairments
—

 
(1,315
)
Operating income
$
16,611

 
$
(7,881
)
Schedule of Revenues by Product Line and Geographic Regions
Net revenues by business unit are as follows:
 
 
Three Months Ended
(In thousands)
 
July 1,
2017
 
July 2,
2016
Plasma
 
$
101,507

 
$
97,649

Blood Center
 
65,565

 
70,943

Cell Processing
 
26,336

 
26,076

Hemostasis Management
 
17,543

 
15,288

Net revenues
 
$
210,951

 
$
209,956

Net revenues generated in our principle operating regions on a reported basis are as follows:
 
Three Months Ended
(In thousands)
July 1,
2017
 
July 2,
2016
United States
$
131,052

 
$
125,700

Japan
14,916

 
14,964

Europe
37,222

 
40,367

Asia
25,940

 
26,992

Other
1,821

 
1,933

Net revenues
$
210,951

 
$
209,956